Artículos por temáticas

Genetics of Alzheimer's disease in Caribbean Hispanic and African American populations

Reitz C, Mayeux R.

Biol Psychiatry. 2014 Apr 1;75(7):534-41. doi: 10.1016/j.biopsych.2013.06.003. Epub 2013 Jul 25.

Amyloid and its association with default network integrity in Alzheimer's disease

Adriaanse SM, Sanz-Arigita EJ, Binnewijzend MA, Ossenkoppele R, Tolboom N, van Assema DM, Wink AM, Boellaard R, Yaqub M, Windhorst AD, van der Flier WM, Scheltens P, Lammertsma AA, Rombouts SA, Barkho

Hum Brain Mapp. 2014 Mar;35(3):779-91. doi: 10.1002/hbm.22213. Epub 2012 Dec 14.

The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations

Liu G, Wang H, Liu J, Li J, Li H, Ma G, Jiang Y, Chen Z, Zhao B, Li K.

Neuromolecular Med. 2014 Mar;16(1):52-60. doi: 10.1007/s12017-013-8250-1. Epub 2013 Jul 28.

A commonly carried genetic variant in the delta opioid receptor gene, OPRD1, is associated with smaller regional brain volumes: replication in elderly and young populations

Roussotte FF, Jahanshad N, Hibar DP, Sowell ER, Kohannim O, Barysheva M, Hansell NK, McMahon KL, de Zubicaray GI, Montgomery GW, Martin NG, Wright MJ, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; ADNI

Hum Brain Mapp. 2014 Apr;35(4):1226-36. doi: 10.1002/hbm.22247. Epub 2013 Feb 21.

Callosal degeneration topographically correlated with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease dementia

Wang PN, Chou KH, Chang NJ, Lin KN, Chen WT, Lan GY, Lin CP, Lirng JF.

Hum Brain Mapp. 2014 Apr;35(4):1529-43. doi: 10.1002/hbm.22271. Epub 2013 May 14.

The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease

Brouillette J.

Curr Pharm Des. 2014;20(15):2506-19. doi: 10.2174/13816128113199990498.

Mitochondrial DNA deletions in Alzheimer's brains: a review

Phillips NR, Simpkins JW, Roby RK.

Alzheimers Dement. 2014 May;10(3):393-400. doi: 10.1016/j.jalz.2013.04.508. Epub 2013 Jul 11.

The GGGGCC repeat expansion in C9ORF72 in a case with discordant clinical and FDG-PET findings: PET trumps syndrome

Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF.

Neurocase. 2014;20(1):110-20. doi: 10.1080/13554794.2012.732090. Epub 2012 Nov 30.

Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study

Lebedev AV, Beyer MK, Fritze F, Westman E, Ballard C, Aarsland D.

Am J Geriatr Psychiatry. 2014 Jan;22(1):4-13.e1. doi: 10.1016/j.jagp.2013.02.004. Epub 2013 Jul 20.

[Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (II)]

Toledano A, Álvarez MI, López-Rodríguez AB, Toledano-Díaz A, Fernández-Verdecia CI.

Neurologia. 2014 Jan-Feb;29(1):42-55. doi: 10.1016/j.nrl.2011.05.004. Epub 2011 Aug 25.

Reduced frequency of T lymphocytes expressing CTLA-4 in frontotemporal dementia compared to Alzheimer's disease

Santos RR, Torres KC, Lima GS, Fiamoncini CM, Mapa FC, Pereira PA, Rezende VB, Martins LC, Bicalho MA, Moraes EN, Reis HJ, Teixeira AL, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:1-5. doi: 10.1016/j.pnpbp.2013.06.019. Epub 2013 Jul 25.

Voxelwise multivariate analysis of multimodality magnetic resonance imaging

Naylor MG, Cardenas VA, Tosun D, Schuff N, Weiner M, Schwartzman A.

Hum Brain Mapp. 2014 Mar;35(3):831-46. doi: 10.1002/hbm.22217. Epub 2013 Feb 13.

Common and unique gray matter correlates of episodic memory dysfunction in frontotemporal dementia and Alzheimer's disease

Irish M, Piguet O, Hodges JR, Hornberger M.

Hum Brain Mapp. 2014 Apr;35(4):1422-35. doi: 10.1002/hbm.22263. Epub 2013 May 14.

Soluble beta amyloid in a continuum from physiology to pathology: searching the determinants of its effects and designing new pharmacological treatments

Trabace L.

Curr Pharm Des. 2014;20(15):2457. doi: 10.2174/13816128113199990511.

Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease

Blennow K, Hampel H, Zetterberg H.

Neuropsychopharmacology. 2014 Jan;39(1):189-201. doi: 10.1038/npp.2013.154. Epub 2013 Jun 25.